Meiji Holdings Co., Ltd. Meiji Holdings Co., Ltd. Financial Results - For the FYE March 2016 -  

Pharma: Focus on Our Expertise to Develop New Drugs

Prev. Page Next Page Download the PDF
ME1111, discovered in-house
 Results of Phase II trial released in December last year
 Did not achieve anticipated results
 Will develop new formulation and redo trial

 Suspended development after a comprehensive review of Phase II trial results

Agricultural chemicals
 Some promising compounds for the future profit

R&D expenses
 Concentrate research fields to effectively inject development expenses